Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3565 | Self-questionnary Wiki | 0.71 |
| drug666 | Budesonide dry powder inhaler Wiki | 0.71 |
| drug2474 | NG test Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D018352 | Coronavirus Infections NIH | 0.05 |
| D007239 | Infection NIH | 0.03 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.03 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There are 2 clinical trials
A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endoscopy practice in the studied countries.
Description: To evaluate the validity of different GI societies recommendations applied locally and how effective they are in preventing transmission in endoscopy units through reporting any new cases developing COVID-19 within two weeks of doing endoscopy (whether a patient or health-care worker)
Measure: Effect of GI societies recommendations on prevention of SARS-CoV-2 infection Time: 4- 6 monthsDescription: To measure the percentage change in performed endoscopic procedure in response to COVID-19 in different centers of the world and the alternative solutions given to overcome this problem.
Measure: To measure the percentage change in performed endoscopic procedure in response to COVID-19 Time: 4- 6 monthsDescription: Effect of COVID-19 precautions on procedure time
Measure: Effect of COVID-19 precautions on procedure time Time: 4- 6 monthsDescription: Effect of COVID-19 precautions on prolongatIon of time of disinfection
Measure: Effect of COVID-19 precautions on time of disinfection Time: 4- 6 monthsDescription: Effect of COVID-19 precautions on the ability of the endoscopist to finish the procedure successfully
Measure: Effect of COVID-19 precautions on procedure success Time: 4- 6 monthsDescription: Effect of COVID-19 precautions on occurrence of complications
Measure: Effect of COVID-19 precautions on complications Time: 4- 6 monthsDescription: Effect of COVID-19 precautions on change of working time (prolongation or shortening)
Measure: Effect of COVID-19 precautions on working time Time: 4- 6 monthsDescription: Effect of COVID-19 precautions on change of staff number
Measure: Effect of COVID-19 precautions on staff number Time: 4- 6 monthsCollect informations on the health status of transplanted patients (kidney, kidney / pancreas, pancreas or pancreatic islet) during the COVID-19 pandemic. All informations will be collected by short questionnaire via phone.
Description: Global Prevalence of COVD-19 infection in transplanted patients
Measure: Global Prevalence of COVID-19 TX Time: From 01st February 2020 to 18 May 2020Description: Hospitalization rate of transplanted patients
Measure: Hospitalization rate in COVID-19 TX Time: From 01st February 2020 to 18 May 2020Description: Correlation between type of transplantation to COVID-19 virus infection
Measure: Correlation COVID-19 TX and type of transplantation Time: From 01st February 2020 to 18 May 2020Description: Prevalence COVID-19 virus infection in transplanted patients in italian provinces
Measure: Prevalence of COVID-19 TX in italian provinces Time: From 01st February 2020 to 18 May 2020Description: Prevalence of different symptoms in COVID-19 virus infection in transplanted patients
Measure: Symptoms in COVID-19 TX Time: From 01st February 2020 to 18 May 2020Description: Correlation between comorbidities to COVID-19 virus infection
Measure: Correlation COVID-19 TX and comorbidities Time: From 01st February 2020 to 18 May 2020Description: Impact of different therapies on COVID-19 virus infection in transplanted patients
Measure: COVID-19 TX Therapies Time: From 01st February 2020 to 18 May 2020Description: Impact of COVID-19 virus infection in transplanted patients family settings
Measure: COVID-19 TX in family settings Time: From 01st February 2020 to 18 May 2020Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports